eTRANSAFE is a research project funded within the Innovative Medicines Initiative (IMI), which aims at developing integrated databases and computational tools (the eTRANSAFE ToxHub) that support the translational safety assessment of new drugs by using legacy data provided by the pharmaceutical companies that participate in the project. The project objectives include the development of databases containing preclinical and clinical data, computational systems for translational analysis including tools for data query, analysis and visualization, as well as computational models to explain and predict drug safety events.

Pognan, F., Steger-hartmann, T., Diaz, C., Blomberg, N., Bringezu, F., Briggs, K., et al. (2021). The etransafe project on translational safety assessment through integrative knowledge management: Achievements and perspectives. PHARMACEUTICALS, 14(3) [10.3390/ph14030237].

The etransafe project on translational safety assessment through integrative knowledge management: Achievements and perspectives

Callegaro G.;
2021

Abstract

eTRANSAFE is a research project funded within the Innovative Medicines Initiative (IMI), which aims at developing integrated databases and computational tools (the eTRANSAFE ToxHub) that support the translational safety assessment of new drugs by using legacy data provided by the pharmaceutical companies that participate in the project. The project objectives include the development of databases containing preclinical and clinical data, computational systems for translational analysis including tools for data query, analysis and visualization, as well as computational models to explain and predict drug safety events.
Articolo in rivista - Articolo scientifico
Data mining; Data sharing; Drug safety; Integrative knowledge management; Predictive modelling; Read across; Toxicology; Translational safety assessment;
English
2021
14
3
237
open
Pognan, F., Steger-hartmann, T., Diaz, C., Blomberg, N., Bringezu, F., Briggs, K., et al. (2021). The etransafe project on translational safety assessment through integrative knowledge management: Achievements and perspectives. PHARMACEUTICALS, 14(3) [10.3390/ph14030237].
File in questo prodotto:
File Dimensione Formato  
Pognan-2021-Pharmaceuticals-VOR.pdf

accesso aperto

Descrizione: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 4.81 MB
Formato Adobe PDF
4.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/511681
Citazioni
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 17
Social impact